CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


07-March-2017
Cerilliant / MilliporeSigma introduces its new pharmaceutical drug spiking solutions®, Trifluoperazine diHCl & (±)-O-Desmethylvenlafaxine (1.0 mg/mL).

Trifluoperazine diHCl T-117
1.0 mg/mL (as free base) in Methanol

A Certified Spiking Solution® suitable for use as starting material in calibrators and controls for trifluoperazine LC/MS or GC/MS testing methods in clinical toxicology, urine drug testing, prescription monitoring, or forensic analysis applications.  Trifluoperazine is a typical antipsychotic drug prescribed primarily for the treatment of schizophrenia.

(±)-O-Desmethylvenlafaxine V-045
1.0 mg/mL in Methanol

An analytical reference standard applicable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications such as urine drug testing, forensic analysis, or clinical toxicology. Also known as desvenlafaxine, O-desmethylvenlafaxine is an SNRI antidepressant marketed under the trade name Pristiq for the treatment of depression. O-desmethylvenlafaxine is also a major urinary metabolite of venlafaxine, an SNRI antidepressant sold as Effexor or Efexor and used to treat major depressive disorder, generalized anxiety disorder, and other anxiety disorders associated with depression.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn